Disease Modifying Therapy in Multiple Sclerosis
| Autor: | U. E. Williams, S. K. Oparah, E. E. Philip-Ephraim |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Autoimmune disease
medicine.medical_specialty business.industry Multiple sclerosis Neurodegeneration Central nervous system Multiple sclerosis research Disease Review Article medicine.disease Bioinformatics Neuroprotection medicine.anatomical_structure Physical medicine and rehabilitation medicine Etiology business |
| Zdroj: | International Scholarly Research Notices |
| ISSN: | 2356-7872 |
| Popis: | Multiple sclerosis is an autoimmune disease of the central nervous system characterized by inflammatory demyelination and axonal degeneration. It is the commonest cause of permanent disability in young adults. Environmental and genetic factors have been suggested in its etiology. Currently available disease modifying drugs are only effective in controlling inflammation but not prevention of neurodegeneration or accumulation of disability. Search for an effective neuroprotective therapy is at the forefront of multiple sclerosis research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text